Cigna Says Bristol-Myers Delayed Cancer Drug Generic Cigna has launched an antitrust suit in New York federal court accusing Bristol-Myers Squibb Co. and its Celgene subsidiary of fraudulently obtaining patents, filing sham litigation and paying off generic-drug makers to maintain a monopoly on their blockbuster blood-cancer drug Pomalyst.
https://www.law360.com/ip/arti....cles/2357343?utm_sou